Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
As Omicron rages, FDA clears Eli Lilly/AbCellera's new antibody days after $720M supply deal
4 years ago
FDA+
FDA postpones adcomm for Pfizer's Covid-19 vaccine for the youngest age group
4 years ago
R&D
Covid-19 roundup: US to pay $725M for Eli Lilly's new mAb, if authorized; WHO chief scientist says more variants are coming
4 years ago
Novavax says its vaccine is 80% effective in teens, but manufacturing questions continue to cloud future
4 years ago
R&D
Covid-19 roundup: New preprint suggests Omicron sub-variant can evade Vir antibody; BioNTech-backed nonprofit undermined WHO equity efforts — report
4 years ago
In final analysis, J&J's underdog vaccine offers only 52.9% protection against Covid-19
4 years ago
R&D
Novavax's vaccine rollout crawls amid months of broken promises — report
4 years ago
Pharma
Covid-19 jab production has stopped at J&J's vaccine birthplace
4 years ago
Manufacturing
Pfizer's Covid-19 vaccine captures the most annual sales of any medical product ever — by more than $15B
4 years ago
Covid-19 roundup: Oxford vaccine scientist says overblown safety fears caused death of 'hundreds of thousands'; Omicron-specific booster may not provide more protection — report
4 years ago
A rarity for ICER: Cost watchdog says Covid-19 therapeutics appropriately priced in the US
4 years ago
Pharma
Exclusive: The curious case of the BioNTech priority review voucher
4 years ago
FDA+
FDA takes a rare step and asks Pfizer to submit a Covid-19 vaccine EUA for the youngest children
4 years ago
FDA+
Covid-19 roundup: Vaccine for the youngest kids may be coming soon; Moderna wins PRV with full approval
4 years ago
After sputtering on the launch pad, Novavax finally gets its EUA application in. Does it matter?
4 years ago
FDA+
Covid-19 roundup: Non-Covid PhIII trials saw steep decline in 2020; Merck's pill is last choice among patients
4 years ago
The Covid-19 vaccine IP waiver is back at the WTO, with a new deadline. Can it muster enough support?
4 years ago
Covid-19 roundup: Watchdog criticizes EU Commission over president's texts; Novavax signs vaccine deal with Israel
4 years ago
Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill
4 years ago
Pfizer wants to help the FDA with its new, court-mandated $4-5M FOIA release on the company's Covid-19 vaccine data
4 years ago
FDA+
Covid-19 roundup: Pfizer/BioNTech launch Omicron-specific vaccine trial; UK to recruit thousands more for molnupiravir study
4 years ago
US restricts use of two monoclonal antibodies that don't work against Omicron
4 years ago
FDA+
Covid-19 roundup: FDA greenlights Gilead's Veklury for outpatient use; WHO head warns world is primed for more variants
4 years ago
Covid-19 roundup: HHS may struggle to absorb Operation Warp Speed; Europe has no plans for a fourth vaccine dose
4 years ago
First page
Previous page
13
14
15
16
17
18
19
Next page
Last page